
REVVITY, INC. — Investor Relations & Filings
Revvity, Inc. is a health science solutions company providing technologies, expertise, and services across the life sciences and diagnostics sectors. The company offers a comprehensive portfolio that supports complete workflows, from initial research and discovery through preclinical and clinical development to diagnostics and cure. Its offerings include a wide range of reagents, consumables, assays, instruments, and software. Revvity also provides specialized contract services for areas such as preclinical drug discovery and clinical genetic testing, alongside licensable technologies. The company serves customers in the pharmaceutical, biotechnology, academic, and diagnostic laboratory markets, as well as contract research organizations.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-Q - REVVITY, INC. (0000031791) (Filer) | 2026-05-12 | English | |
| 8-K - REVVITY, INC. (0000031791) (Filer) | 2026-05-05 | English | |
| 8-K | 2026-05-01 | English | |
| Major Shareholding Notification 2026 | 2026-04-30 | English | |
| SCHEDULE 13G/A - REVVITY, INC. (0000031791) (Subject) | 2026-03-27 | English | |
| ARS | 2026-03-16 | English |
Browse filings by year
27 years- 2026 27 filings
- 2025 65 filings
- 2024 81 filings
- 2023 59 filings
- 2022 62 filings
- 2021 84 filings
- 2020 67 filings
- 2019 68 filings
- 2018 84 filings
- 2017 68 filings
- 2016 74 filings
- 2015 66 filings
- 2014 76 filings
- 2013 64 filings
- 2012 72 filings
- 2011 58 filings
- 2010 63 filings
- 2009 54 filings
- 2008 64 filings
- 2007 64 filings
- 2006 42 filings
- 2005 68 filings
- 2004 42 filings
- 2003 29 filings
- 2002 30 filings
- 2001 30 filings
- 2000 15 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 45339387 | 10-Q - REVVITY, INC. (0000031791) (Filer) | 2026-05-12 | English | ||
| 41334860 | 8-K - REVVITY, INC. (0000031791) (Filer) | 2026-05-05 | English | ||
| 45915268 | 8-K | 2026-05-01 | English | ||
| 45915271 | Major Shareholding Notification 2026 | 2026-04-30 | English | ||
| 33062730 | SCHEDULE 13G/A - REVVITY, INC. (0000031791) (Subject) | 2026-03-27 | English | ||
| 45915276 | ARS | 2026-03-16 | English | ||
| 45915281 | DEFA14A | 2026-03-16 | English | ||
| 45915297 | DEF 14A | 2026-03-16 | English | ||
| 45915317 | PRE 14A | 2026-03-06 | English | ||
| 32875839 | 4 - REVVITY, INC. (0000031791) (Filer) | 2026-02-26 | English | ||
| 32875840 | 4 - REVVITY, INC. (0000031791) (Filer) | 2026-02-25 | English | ||
| 32875848 | 10-K - REVVITY, INC. (0000031791) (Filer) | 2026-02-24 | English | ||
| 32875841 | 4 - REVVITY, INC. (0000031791) (Filer) | 2026-02-19 | English | ||
| 32875842 | 4 - REVVITY, INC. (0000031791) (Filer) | 2026-02-19 | English | ||
| 32875843 | 4 - REVVITY, INC. (0000031791) (Filer) | 2026-02-19 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
REVVITY, INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/30616/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=30616 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=30616 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=30616 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 30616}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for REVVITY, INC. (id: 30616)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.